VHL-SF1

VHL-SF2

Belzutifan(Welireg, 维利瑞)

C₁₇H₁₂F₃NO₄S

AR2-VHL-SF2

CEP1347-VHL-02

AR-VHL-SF2

liver disease program

CRBN-6-5-5-VHL

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda